Citation Tools

Extended report
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Download to a citation manager

Cite this article as:
Smolen JS, Emery P, Ferraccioli GF, et al
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial